Sevoflurane

Sevoflurane shifts neuronal activity toward inhibition by enhancing signaling through GABA-A and glycine receptors while reducing excitatory neurotransmission. This combined effect decreases central nervous system activity and contributes to changes in anesthetic depth. Understanding the balance between inhibitory and excitatory pathways helps explain both its pharmacologic action and the need to adjust administration according to the desired clinical effect.

Low blood-gas solubility allows sevoflurane to move efficiently between the lungs and blood, supporting relatively rapid changes in brain anesthetic concentration. As a result, clinicians can adjust anesthetic depth with greater control during induction and maintenance. This property also contributes to rapid recovery when administration is reduced or stopped, making concentration changes clinically useful.

Sevoflurane's nonpungent character makes inhaled administration more acceptable during mask induction. This is particularly relevant when anesthesia must begin through a mask rather than another route. The property supports a practical induction approach while the anesthetic concentration is controlled through the delivery system, allowing clinicians to initiate anesthesia and modify depth under monitored conditions.

Dose-dependent effects and metabolism are important considerations when evaluating sevoflurane. Increasing exposure changes anesthetic effect, while metabolic handling contributes to the drug's overall pharmacologic profile. These factors must be considered alongside potential adverse reactions rather than evaluated in isolation. Pharmacology-based assessment therefore supports individualized administration and safer management throughout the perioperative period.

Delivery uses a calibrated vaporizer that regulates the anesthetic concentration provided to the patient. Clinicians adjust the concentration according to the required anesthetic depth while maintaining continuous observation of ventilation, circulation, and anesthetic concentration. This workflow links accurate equipment performance with physiologic monitoring, helping detect changes promptly and maintain controlled administration during induction and maintenance.

Ventilation, circulation, and anesthetic concentration require continuous monitoring during sevoflurane administration. These measurements show how the patient is responding physiologically and whether the delivered concentration remains appropriate for the intended anesthetic depth. Monitoring also provides context for recognizing dose-related effects or potential adverse reactions, supporting timely adjustment of the vaporizer and perioperative care.